For example, in patients with breast cancer, low DPP6 expression predicts unfavorable prognosis, which is consistent with Ke et al. 's finding that DPP6 expression level in ULMS is significantly lower than that in ULM 39. Here, DPP6 is linked to breast carcinoma.